•$Anika Therapeutics (ANIK.US)$+5% (receives FDA 510(k) clearance for the X-Twist knotless fixation system expanding its sports medicine soft tissue portfolio)
•$Mirati Therapeutics (MRTX.US)$+3.2% (submits marketing authorization application for adagrasib to the EMA; also upgraded to Buy from Neutral at Guggenheim)
•$Atara Biotherapeutics (ATRA.US)$-3.1% (ATRA says Bayer (BAYR.Y) intends to end licensing agreement for next-gen mesothelin-directed CAR T-cell therapies)
•$Kohl's Corp (KSS.US)$-2.3% (Macellum Issues Statement Regarding the Kohl's Board's Apparent Breach of Fiduciary Duty and Failure to Disclose Material Information Prior to 2022 Annual Meeting)
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.